Virological characteristics of the SARS-CoV-2 Omicron BA.2.75
Akatsuki Saito(University of Miyazaki), Kei Sato(University of Tokyo Hospital)
Cited by 44
Related Papers
SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant
|Cell Reports|2020|438
An emerging SARS-CoV-2 mutant evading cellular immunity and increasing viral infectivity
|bioRxiv (Cold Spring Harbor Laboratory)|2021|74